Cadrenal Therapeutics: annual report for the year ended Dec 31, 2022
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001213900-23-024260
- Document
- 10-K
- Exhibit 4.11
- Description of securities
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Curis CRIS public float $25M, Jun 30, 2025
- Kala Bio KALA public float $25M, Jun 30, 2025
- Lexaria Bioscience LEXX public float $25M, Feb 28, 2025, over 18 months old
- Pulmatrix PULM public float $25M, Jun 30, 2025
- Dyadic International DYAI public float $24M, Jun 30, 2025
